[go: up one dir, main page]

TNSN98190A1 - Derive d'indole utile en therapeutique, procede pour sa production et formulation pharmaceutique le contenant - Google Patents

Derive d'indole utile en therapeutique, procede pour sa production et formulation pharmaceutique le contenant

Info

Publication number
TNSN98190A1
TNSN98190A1 TNTNSN98190A TNSN98190A TNSN98190A1 TN SN98190 A1 TNSN98190 A1 TN SN98190A1 TN TNSN98190 A TNTNSN98190 A TN TNSN98190A TN SN98190 A TNSN98190 A TN SN98190A TN SN98190 A1 TNSN98190 A1 TN SN98190A1
Authority
TN
Tunisia
Prior art keywords
production
pharmaceutical formulation
same
formulation containing
therapeutics
Prior art date
Application number
TNTNSN98190A
Other languages
English (en)
Inventor
Challenger Stephen
Neil Dack Kevin
Michael Derrick Andrew
Peter Dickinson Roger
Ellis David
Hajikarimian Youssef
James Kim
James Rawson David
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of TNSN98190A1 publication Critical patent/TNSN98190A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L’INVENTION CONCERNE L’ACIDE S-( +)-3-{1-(1,3- BENZODIOXOL-5-Yl) –2-[ (2-METHOXY-4 METHYLPHENYL) SULFONYL-AMINO] –2-OXOETHYL} - 1 - METHYL-1H-INDOLE-6- CARBOXYLIQUE PRATIQUEMENT DEPOURVU DE SON ENANTIOMERE ® -(-), ET SES DERIVES PHARMACEUTIQUEMENT ACCEPTABLES . ELLE COMPREND EGALEMENT UN PROCEDE POUR SA PRODUCTION ET UNE FORMULATION PHARMACEUTIQUE LE CONTENANT. APPLICATION : UTILISATION DANS LE TRAITEMENT DE L'INSUFFISANCE RENAL AIGUE, D'UNE RESTENOSE ET L'HYPERTENSION PULMONAIRE.
TNTNSN98190A 1997-10-22 1998-10-21 Derive d'indole utile en therapeutique, procede pour sa production et formulation pharmaceutique le contenant TNSN98190A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9722287.1A GB9722287D0 (en) 1997-10-22 1997-10-22 Compounds useful in therapy

Publications (1)

Publication Number Publication Date
TNSN98190A1 true TNSN98190A1 (fr) 2005-03-15

Family

ID=10820904

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN98190A TNSN98190A1 (fr) 1997-10-22 1998-10-21 Derive d'indole utile en therapeutique, procede pour sa production et formulation pharmaceutique le contenant

Country Status (17)

Country Link
US (1) US6211223B1 (fr)
AP (1) AP899A (fr)
AR (1) AR014922A1 (fr)
AU (1) AU1150999A (fr)
BG (1) BG104394A (fr)
CA (1) CA2308478C (fr)
CZ (1) CZ20001514A3 (fr)
DZ (1) DZ2628A1 (fr)
GB (1) GB9722287D0 (fr)
GT (1) GT199800161A (fr)
MA (1) MA26556A1 (fr)
MY (1) MY117148A (fr)
PA (1) PA8461001A1 (fr)
TN (1) TNSN98190A1 (fr)
TW (1) TW483893B (fr)
WO (1) WO1999020623A1 (fr)
ZA (1) ZA989574B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9722287D0 (en) 1997-10-22 1997-12-17 Pfizer Ltd Compounds useful in therapy
AR037097A1 (es) 2001-10-05 2004-10-20 Novartis Ag Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento
CN106631920B (zh) * 2016-11-17 2018-11-13 贵州大学 一种2-羟基-4-甲基苯磺酸的制备方法
CN114507162A (zh) * 2020-11-16 2022-05-17 尚科生物医药（上海）有限公司 一种制备2-氟-5-甲氧基苯磺酰氯的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0617001T3 (da) * 1993-03-19 2000-04-17 Merck & Co Inc Phenoxyphenyleddikesyrederivater
GB9609641D0 (en) * 1996-05-09 1996-07-10 Pfizer Ltd Compounds useful in therapy
GB9722287D0 (en) 1997-10-22 1997-12-17 Pfizer Ltd Compounds useful in therapy

Also Published As

Publication number Publication date
AU1150999A (en) 1999-05-10
CZ20001514A3 (cs) 2001-09-12
GT199800161A (es) 2000-04-11
AP899A (en) 2000-11-17
BG104394A (en) 2001-09-28
DZ2628A1 (fr) 2003-03-08
MA26556A1 (fr) 2004-12-20
AR014922A1 (es) 2001-04-11
PA8461001A1 (es) 2000-05-24
MY117148A (en) 2004-05-31
CA2308478C (fr) 2004-12-07
TW483893B (en) 2002-04-21
ZA989574B (en) 2000-04-25
GB9722287D0 (en) 1997-12-17
US6211223B1 (en) 2001-04-03
WO1999020623A1 (fr) 1999-04-29
AP9801370A0 (en) 1998-12-31
CA2308478A1 (fr) 1999-04-29

Similar Documents

Publication Publication Date Title
TNSN97078A1 (fr) Derives d'indole nouveaux, procede pour leur preparation et formulations pharmaceutiques les contenant
TNSN98216A1 (fr) Derives d'acide hydrauxamique, compositions pharmaceutiques les contenant et procede pour leur preparation
TNSN97193A1 (fr) Amides inhibiteurs de secretion de apo b/mtp, procede pour leur preparation et compositions pharmaceutiques les contenant.
UA44254C2 (uk) Похідні 4-(заміщеного феніламіно)хіназоліну, спосіб їх одержання, спосіб лікування і фармацевтична композиція
TNSN98083A1 (fr) Derives de 6-0 methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant.
ATE201203T1 (de) Chirale methylphenyloxazolidinone
EA200000245A1 (ru) Быстро дезинтегрирующие таблетки метилцеллюлозы
HUT68357A (en) Heterocyclic-cyclic-amine derivatives, pharmaceutical compositions containing them and process for their production
NO179250C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktiv (+)--(2,3-dimetoksyfenyl)-1-[2-(4-fluorfenyl)etylÅ-4-piperidinmetanol
FR2780403B3 (fr) Nouvelle forme de l'irbesartan, procedes pour obtenir ladite forme et compositions pharmaceutiques en contenant
TNSN99126A1 (fr) Pyrrolopyrimidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN98155A1 (fr) Associations de compositions pharmaceutiques d'atorvastatine et d'agents antihypertensifs, et procede pour leur preparation
RU95110938A (ru) Производные 1-(2-оксоацетил)пиперидин-2-карбоновых кислот, фармацевтическая композиция, способ лечения, способ получения
EA200000246A1 (ru) Быстро дезинтегрирующие таблетки метилцеллюлозы
DE69534564D1 (de) Verwendung von 2-hydroxy-5-phenylazobenzoesäure-derivaten als wirkstoffe zur chemoprävention und chemotherapie von kolonkrebs
TNSN98127A1 (fr) Derives d'azetidinylpropylpiperidine , procede pour leur preparation et compositions pharmaceutiques les contenant.
DE69632193D1 (de) Cyclooxygenaseinhibitor und salze von amidinderivaten, verfahren zu deren herstellung, deren verwendung als arzneiwirkstoffe sowie diese salze enthaltende arzneimittel
CA2176668A1 (fr) Nouveaux composes spiro heterocycliques, leur procede de preparation et les compositions pharmaceutiques les contenant
SE9003904D0 (sv) Method for the manufacture of a pharmaceutical dosage form
ATE259369T1 (de) Neue geranylgeranylderivate, verfahren zu deren herstellung und entsprechende pharmazeutische zusammensetzungen
TNSN98190A1 (fr) Derive d'indole utile en therapeutique, procede pour sa production et formulation pharmaceutique le contenant
TNSN99221A1 (fr) Derive d'indole nouveau, procede pour sa preparation et compositions pharmaceutiques le contenant
DK0823909T3 (da) Hidtil ukendte heterocykliske forbindelser
FR2669221B1 (fr) Procede de preparation par compression directe de comprimes de derives de l'acide cephalosporanique.
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.